Stryker Submits OP-1 Implant For U.S., European Approval

Creative BioMolecules, Inc. announced that Stryker Corp., its partner in orthopedic and dental reconstruction, has submitted applications in both the United States and Europe seeking marketing approval for the OP-1 bone graft device, also known as the OP-1 Implant.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news